Apex Healthcare Bhd (XKLS:7090) GF Value Rank: 3 (As of Jul. 30, 2026) — 40% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7090 Apex Healthcare Bhd XKLS:7090
63 GF Score
Price RM2.61
GF Value RM2.27
! 8 Warning Signs
View Full Analysis

What is Apex Healthcare Bhd GF Value Rank?

Apex Healthcare Bhd XKLS:7090 63 GF Value Rank is 3 as of Jul. 30, 2026, which is 40% below its 10-year median of 5.00. GuruFocus rates XKLS:7090 with a GF Score™ of 63/100 and a GF Value™ of RM2.27. The stock has 8 warning signs investors should review.

Apex Healthcare Bhd has the GF Value Rank of 3.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Apex Healthcare Bhd GF Value Rank Related Terms


XKLS:7090 vs MCK, COR, CAH: GF Value Rank Comparison

For the Medical Distribution subindustry, Apex Healthcare Bhd's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Healthcare Bhd GF Value Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Apex Healthcare Bhd's GF Value Rank falls into.


XKLS:7090
63GF Score
Apex Healthcare Bhd XKLS:7090
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 3 mean?
Apex Healthcare Bhd (XKLS:7090) has a GF Value Rank of 3 as of Jul. 30, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Apex Healthcare Bhd and its competitors. This is 40% below median its historical median of 5.00. Over the past decade, Apex Healthcare Bhd's GF Value Rank has ranged from 1.00 to 10.00.
Is Apex Healthcare Bhd's GF Value Rank too high?
Apex Healthcare Bhd's current GF Value Rank of 3 is 40% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's GF Value Rank compare to MCK and COR?
Apex Healthcare Bhd's GF Value Rank of 3 can be compared against companies in the Medical Distribution industry. Historically, Apex Healthcare Bhd's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Distribution company?
A good GF Value Rank depends on the Medical Distribution industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Apex Healthcare Bhd and its competitors. Apex Healthcare Bhd's current GF Value Rank is 3, which is 40% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current GF Value Rank of 3. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current GF Value Rank is 3, which is 40% below median its 10-year median of 5.00. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current GF Value Rank is 3 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued. The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.

Key valuation signals for XKLS:7090:

  • GF Value Rank: 3 (40% below median its 10-year median of 5.00)
  • GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apex Healthcare Bhd Business Description

Address 1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score

Get the complete analysis for XKLS:7090

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.61
Price
RM2.27
GF Value